KitoTech Medical

Biotechnology, Health Care, Manufacturing, Medical Device
Founded in 1/1/11
Seattle, Washington, United States
For Profit

About KitoTech Medical

KitoTech Medical is a medical device company developing and commercializing products for wound closure and wound care. It has developed and introduced a revolutionary proprietary wound closure product, microMend, onto the market. It incorporates tiny Microstaples on an adhesive backing, which is the size and shape of a butterfly bandage. microMend is painless and as easy to apply as a bandage. The Microstaples provide the holding strength of sutures resulting in secure anchoring of the device to the skin. These features make microMend ideal for closing surgical incisions and lacerations currently closed with sutures and staples. Clinical studies have demonstrated its superiority over sutures in terms of clinical outcomes, including cosmetic results. It is much faster than sutures and can be applied by less costly medical personnel (nurses, PAs, and nursing assistants) translating into significant cost savings in wound closure procedures. microMend is being marketed in a broad range of surgical specialties as well as dermatology and emergency medicine. The military represents an additional major market for microMend, where the product is also being commercialized. Its potential market is over $600M and $2B in the US and worldwide, respectively. KitoTech Medical was founded in 2011 and is based in Seattle, Washington.

Company Metrics

  • Employees: 11-50
  • Monthly Visits: None
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue: Less than $1M
  • Total Funding: 15927480 USD
  • Last Funding: 2000000 USD (Series B)
  • Funding Status: Early Stage Venture

Technology Stack

KitoTech Medical actively uses None products in their tech stack.

Market Presence

Industries: Biotechnology, Health Care, Manufacturing, Medical Device

Headquarters: Seattle, Washington, United States

Leadership

  • Ronald Berenson - President and CEO LinkedIn